US Stock Futures and Bond Yields Decline After Reports of Updated Russian Nuclear Doctrine Standard Chartered CEO Apologizes for Controversial Lower Value Human Capital Remark Arsenals Brand Power How Cultural Reach Sustains Commercial Value Despite OnField Struggles The Mandalorian and Grogu Draws Strong Early Praise Could Reinvigorate Star Wars Franchise General Motors Introduces AllElectric Cadillac Vistiq with 300Mile Range Oil Supply Crunch Expected Later Than Initially Anticipated Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development WaFd Inc WAFD Q1 2026 Earnings Earnings Beat Surprises Markets Yet Shares Slip First Solar FSLR Q1 2026 Earnings EPS Surges Past Estimates as Operational Strength Drives Confidence SCVL Q1 2026 Earnings Modest Miss on EPS Amid Challenging Retail Environment NextDecade Corporation Q1 2026 Earnings EPS Surprise Beats Estimates Amid PreRevenue Phase American Financial Group Q1 2026 Earnings EPS Misses Estimates Amid Premium Growth Headwinds SmithMidland SMID Gains 33 as Price Nears Key Resistance Level inTest Corporation INTT Holds Steady Near 1829 as Semiconductor Sector Faces Crosscurrents CRA International CRAI Modestly Advances Above Key Support as Trading Remains Measured Anixa Biosciences ANIX Slides 215 as Biotech Sector Headwinds Return Urban Edge Properties UE Posts Slight Gain as Stock Holds Above Support Level Tony Blairs Economic Diagnosis Praised but AIFocused Prescription Questioned by Analysts ClearSign Technologies CLIR Q1 2026 Earnings WiderThanExpected Loss Stalls Recovery Hopes Washington Trust Bancorp WASH Holds Near Support as Slight Dip Tests Key Levels Context Therapeutics Inc CNTX Shows Modest Gains Near Key Resistance Level Fulcrum Therapeutics FULC Hovers Near Support After Marginal Uptick Templeton Dragon Fund TDF Holds Near 1118 in Tight Range Minor Gain Signals Consolidation Aclaris Therapeutics ACRS Gains 244 as Buyers Defend Key Support Zone Ioneer Ltd IONR Rises 218 as Shares Approach Key Resistance Level SLM Corporation Rallies Testing Resistance Near 2326 Entrada Therapeutics TRDA Edges Lower Amid Light Trading Key Support at 617 in Focus